ePrints

Advances in primary immunodeficiencies

Lookup NU author(s): Dr Alexandra Battersby, Professor Andrew Cant

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

© 2016 Elsevier Ltd Primary Immunodeficiencies (PID) although rare are serious; diagnosis is often delayed due to their non-specific presentation. The concept of PID has changed in recent years to a broader clinical phenotype, including autoimmunity, malignancy, immune dysregulation and allergy. Improved genetic diagnostics has greatly improved both our understanding of PID and our approach to diagnosis, enabling more accurate delineation. Haematopoietic Stem Cell Transplantation (HSCT) is an increasingly successful curative treatment for a widening range of severe PIDs; survival following HSCT is now 90% due to better preparation, less toxic chemotherapy, improved donor matching, better manipulation of stem cells and improved management of complications. Quality of life for PIDs such as Chronic Granulomatous Disease (CGD) is markedly better after HSCT than with supportive care. This article outlines the advances made in this rapidly advancing field in the last decade and offers practical advice on investigation and management of suspected or confirmed PID for the general paediatrician.

Publication metadata

Author(s): Battersby AC, Cant AJ

Publication type: Review

Publication status: Published

Journal: Paediatrics and Child Health

Year: 2017

Volume: 27

Issue: 3

Pages: 116-120

Print publication date: 01/03/2017

Online publication date: 02/12/2016

Acceptance date: 02/04/2016

ISSN (print): 1751-7222

ISSN (electronic): 1878-206X

Publisher: Churchill Livingstone

URL: https://doi.org/10.1016/j.paed.2016.11.001

DOI: 10.1016/j.paed.2016.11.001

Share